Hemostasis is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of wound healing.
Tissue sealing agents are used during medical procedures to achieve hemostasis. They vary based on their mechanism of action, composition, ease of application, adherence to tissue, immunogenicity and cost. These agents permit rapid hemostasis, better Visualization of the surgical area, shorter operative times, decreased requirement for transfusions, decreased wound healing time and overall improvement in patient recovery time.
The classification of Hemostasis and Tissue Sealing Agents includes Hemostasis and Tissue Sealing Agents and the revenue proportion of Hemostasis Agent in 2017 is about 64%
North America is the largest consumption place, with a consumption market share nearly 42% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
The global Hemostasis and Tissue Sealing Agents market is valued at 2810 million US$ in 2018 and will reach 4470 million US$ by the end of 2025, growing at a CAGR of 6.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hemostasis and Tissue Sealing Agents market based on company, product type, end user and key regions.
This report studies the global market size of Hemostasis and Tissue Sealing Agents in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hemostasis and Tissue Sealing Agents in these regions.
This research report categorizes the global Hemostasis and Tissue Sealing Agents market by top players/brands, region, type and end user. This report also studies the global Hemostasis and Tissue Sealing Agents market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Johnson & Johnson
C R Bard
Integra Life Sciences
Advance Medical Solution
Ferrosan Medical Devices
Smith & Nephew
Market size by Product
Tissue Sealing Agents
Market size by End User
Minimally Invasive Surgery
Market size by Region
Central & South America
Rest of Central & South America
Middle East & Africa
The study objectives of this report are:
To study and analyze the global Hemostasis and Tissue Sealing Agents market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Hemostasis and Tissue Sealing Agents market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Hemostasis and Tissue Sealing Agents companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Hemostasis and Tissue Sealing Agents submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Hemostasis and Tissue Sealing Agents are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hemostasis and Tissue Sealing Agents market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.